July 03, 2025

Celiac, Thyroid Diseases Linked to Diabetes Risk

A large US-based study found that people with celiac disease, hyperthyroidism, or hypothyroidism face a two- to threefold increased risk of developing type 1 diabetes, with the highest risk seen in children.

Conexiant

June 30, 2025

Online Genetic Testing Platform Demonstrates Notable Engagement Among Patients With Young-Onset Colorectal Cancer

In a pilot study being presented at the 2025 ASCO Annual Meeting, Moskowitz et al developed and evaluated an online platform that enables patients with young-onset colorectal cancer to access educatio...

The ASCO Post

June 30, 2025

Invitation to Colonoscopy vs Fecal Immunochemical Test Screening for Colorectal Cancer

Does being invited to colorectal cancer screening with fecal immunochemical tests vs colonoscopy have an impact on colorectal cancer mortality?

The ASCO Post

June 30, 2025

Reduced-Dose Chemoradiotherapy in Early-Stage Anal Cancer

In a UK phase II trial (PLATO-ACT4) reported in The Lancet Oncology, Gilbert et al compared short-term response rates of standard- vs reduced-dose chemoradiotherapy in patients with localized squamous...

The ASCO Post

June 30, 2025

Reduced-Dose Chemoradiotherapy for Early-Stage Anal Cancer

In a UK phase II trial (PLATO-ACT4) reported in The Lancet Oncology, Gilbert et al evaluated whether short-term results showed good complete response rates with both standard-dose and reduced-dose che...

The ASCO Post

June 30, 2025

Childhood Exposure to Bacterial Toxin May Trigger Early-Onset Colorectal Cancer

Researchers may have identified a bacterial toxin as a potential factor contributing to the concerning rise in early-onset colorectal cancer.

The ASCO Post

June 30, 2025

Encorafenib/Cetuximab Plus Chemotherapy Improves Survival in BRAF V600E–Mutant Metastatic Colorectal Cancer

The targeted combination of encorafenib and cetuximab plus mFOLFOX6 chemotherapy may be a new first-line standard of care for certain patients with advanced colorectal cancer.

The ASCO Post

June 30, 2025

ASCO 2025: Adding Atezolizumab to Adjuvant Chemotherapy Improves Disease-Free Survival in dMMR Colon Cancer

Results from the phase III ATOMIC study demonstrated that patients with deficient mismatch repair (dMMR) colon cancer who receive atezolizumab in addition to adjuvant chemotherapy experience a 50% red...

The ASCO Post

June 30, 2025

Incidence Rates of Colorectal and Pancreatic Cancers Are Rising Most Among Young Adults

“Clinicians should be aware of this trend in younger age groups, so their suspicion is higher when patients present with symptoms.”

The ASCO Post